NVP-BVU972
NVP-BVU972 is an selective and potent Met inhibitor, with an IC50 of 14 nM. NVP-BVU972 also exhibits good anti-proliferative activity against Met with drug-resistant mutations and inhibits phosphorylation. NVP-BVU972 can be used in study of cancer[1].
Product Specifications
CAS Number
1185763-69-2
UNSPSC
12352005
Hazard Statement
H317, H319
Target
C-Met/HGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/NVP-BVU972.html
Purity
98.78
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CN1N=CC(C2=NN3C(C=C2)=NC=C3CC4=CC=C(N=CC=C5)C5=C4)=C1
Molecular Formula
C20H16N6
Molecular Weight
340.38
Precautions
H317, H319
References & Citations
[1]Tiedt, Ralph, et al. A Drug Resistance Screen Using a Selective MET Inhibitor Reveals a Spectrum of Mutations That Partially Overlap with Activating Mutations Found in Cancer Patients. Cancer Research (2011), 71 (15), 5255-5264.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC402511-500 1x 500 µL
CD68 (Macrophage Marker) (C68/2511), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
